(Q38001827)

26 August 2017

title

Pulmonary embolism and deep vein thrombosis (English)

1 reference

26 August 2017

0 references

Samuel Z Goldhaber

1

1 reference

26 August 2017

Henri Bounameaux

series ordinal

2

1 reference

26 August 2017

language of work or name

English

0 references

publication date

10 April 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

379

1 reference

26 August 2017

issue

9828

1 reference

26 August 2017

page(s)

1835-1846

1 reference

Clinical practice. Deep-vein thrombosis of the upper extremities

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Incidence and mortality of venous thrombosis: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

A prospective study of the incidence of deep-vein thrombosis within a defined urban population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

The epidemiology of venous thromboembolism in the community

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Factors associated with adverse outcomes in outpatients presenting with pulmonary embolism: the Worcester Venous Thromboembolism Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Long-term cardiovascular and noncardiovascular mortality of 1023 patients with confirmed acute pulmonary embolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Chronic thromboembolic pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

The post-thrombotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Patient outcomes after acute pulmonary embolism. A pooled survival analysis of different adverse events

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Venous thromboembolism and atherothrombosis: an integrated approach

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Current management of acute myocardial infarction: experience from the Korea Acute Myocardial Infarction Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

C-reactive protein and venous thromboembolism. A prospective investigation in the ARIC cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Meta-analysis: travel and risk for venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Smoking and venous thromboembolism: a Danish follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

New evidence on the potential role of the metabolic syndrome as a risk factor for venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Living near major traffic roads and risk of deep vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Venous thromboembolism in women using hormonal contraceptives. Findings from the RIETE Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Thrombosis in cancer: an update on prevention, treatment, and survival benefits of anticoagulants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Pulmonary embolism in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Should patients with venous thromboembolism be screened for thrombophilia?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Deep venous thrombosis or pulmonary embolism and factor V Leiden: enigma or paradox.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Risk assessment for recurrent venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Appropriateness of diagnostic management and outcomes of suspected pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Prediction of pulmonary embolism in the emergency department: the revised Geneva score.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Value of assessment of pretest probability of deep-vein thrombosis in clinical management.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

D-Dimer for venous thromboembolism diagnosis: 20 years later

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

VIDAS D-dimer in combination with clinical pre-test probability to rule out pulmonary embolism. A systematic review of management outcome studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Observer dependency of the SimpliRed D-dimer assay in 81 consecutive patients with suspected pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

The challenge of diagnosing pulmonary embolism in elderly patients: influence of age on commonly used diagnostic tests and strategies.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Potential of an age adjusted D-dimer cut-off value to improve the exclusion of pulmonary embolism in older patients: a retrospective analysis of three large cohorts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Risk of deep vein thrombosis following a single negative whole-leg compression ultrasound: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Clinical relevance of distal deep vein thrombosis. Review of literature data.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Non-invasive diagnostic work-up of patients with clinically suspected pulmonary embolism; results of a management study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Performance of helical computed tomography in unselected outpatients with suspected pulmonary embolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Use of spiral computed tomography contrast angiography and ultrasonography to exclude the diagnosis of pulmonary embolism in the emergency department

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Diagnostic strategy for patients with suspected pulmonary embolism: a prospective multicentre outcome study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Peripheral pulmonary arteries: how far in the lung does multi-detector row spiral CT allow analysis?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Multidetector-Row Computed Tomography in Suspected Pulmonary Embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Diagnosis of pulmonary embolism by multidetector CT alone or combined with venous ultrasonography of the leg: a randomised non-inferiority trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Meta-analysis: outcomes in patients with suspected pulmonary embolism managed with computed tomographic pulmonary angiography.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Clinical validity of a normal pulmonary angiogram in patients with suspected pulmonary embolism--a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Challenges in the diagnosis of acute pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Multidetector computed tomography for acute pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Systematic review and meta-analysis of strategies for the diagnosis of suspected pulmonary embolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Derivation and validation of a prognostic model for pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Massive pulmonary embolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Acute pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Dabigatran versus warfarin in the treatment of acute venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Oral rivaroxaban for symptomatic venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Is laboratory monitoring of low-molecular-weight heparin therapy necessary? No.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Subcutaneous Fondaparinux versus Intravenous Unfractionated Heparin in the Initial Treatment of Pulmonary Embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Warfarin dose requirement and CYP2C9 polymorphisms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Genetic determinants of response to warfarin during initial anticoagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Self-monitoring and self-management of oral anticoagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Meta-analysis: effect of patient self-testing and self-management of long-term anticoagulation on major clinical outcomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Effect of home testing of international normalized ratio on clinical events

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Recurrent venous thromboembolism during coumarin therapy. Data from the computerised registry of patients with venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Validation of a diagnostic approach to exclude recurrent venous thromboembolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

D-dimer testing to determine the duration of anticoagulation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Thrombosis: Duration of anticoagulation after VTE: guided by ultrasound?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

New oral antithrombotics: a need for laboratory monitoring. Against

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Increasing use of vena cava filters for prevention of pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Venous thromboembolism in the outpatient setting

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Aggregating and disaggregating patients in clinical trials and their subgroup analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Predictive and associative models to identify hospitalized medical patients at risk for VTE.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Thromboprophylaxis rates in US medical centers: success or failure?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Double trouble for 2,609 hospitalized medical patients who developed deep vein thrombosis: prophylaxis omitted more often and pulmonary embolism more frequent.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Improving Practices in US Hospitals to Prevent Venous Thromboembolism: lessons from ENDORSE.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Lack of prophylaxis before the onset of acute venous thromboembolism among hospitalized cancer patients: the SWIss Venous ThromboEmbolism Registry (SWIVTER)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Adherence to pharmacological thromboprophylaxis orders in hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Computerized decision support for the cardiovascular clinician: applications for venous thromboembolism prevention and beyond

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Electronic alerts to prevent venous thromboembolism among hospitalized patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Multi-screen electronic alerts to augment venous thromboembolism prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Maintained effectiveness of an electronic alert system to prevent venous thromboembolism among hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Physician alerts to prevent symptomatic venous thromboembolism in hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

Eradication of hospital-acquired venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961904-1

7 January 2021

10.1016/S0140-6736(11)61904-1

Identifiers

DOI

1 reference

26 August 2017

1 reference